Search results
How Hypertrophic Cardiomyopathy Progresses in Adults
Time via Yahoo News· 1 month agoTreatment sometimes involves an implantable defibrillator. Credit - Karsten Eggert—Getty Images Hypertrophic cardiomyopathy is the most common form of...
Dr. Hersh: Hypertrophic cardiomyopathy occurs when heart muscle becomes too thick
The Metrowest Daily News via Yahoo News· 2 months agoHypertrophic cardiomyopathy (HCM) is a condition where some of the heart muscle becomes too thick,...
How Hypertrophic Cardiomyopathy Is Treated
Verywell Health via Yahoo News· 2 years agoThe primary treatment options for hypertrophic cardiomyopathy (HCM) are medications like beta-blockers and calcium channel blockers. Lifestyle changes...
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets Goals
Zacks via Yahoo Finance· 4 months agoCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in...
How to Talk to Your Family About Their Heart Health History
Time via Yahoo News· 3 weeks agoCredit - Dimitri Otis—Getty Images Hypertrophic obstructive cardiomyopathy (HOCM) is the most common...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 4 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
Investor's Business Daily· 3 months agoCytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double over a month as...
Bristol Myers (BMY) Gets FDA Nod for Data Addition to Camzyos
Zacks via Yahoo Finance· 10 months agoBristol Myers Squibb BMY announced that the FDA approved the supplemental new drug application...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle
Benzinga via Yahoo Finance· 1 year agoCytokinetics Incorporated (NASDAQ: CYTK) presented results from Cohort 4 of REDWOOD-HCM Phase 2...
